lauric acid has been researched along with Arterial Occlusive Diseases in 5 studies
dodecanoic acid : A straight-chain, twelve-carbon medium-chain saturated fatty acid with strong bactericidal properties; the main fatty acid in coconut oil and palm kernel oil.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| " tail gangrene induced by subcutaneous injections of both ergotamine and epinephrine in rats." | 3.67 | Effect of beraprost sodium on peripheral circulation insufficiency in rats and rabbits. ( Amemiya, K; Murai, T; Muraoka, K; Murata, T; Nishio, S; Saga, K; Sakai, A; Sato, N; Umetsu, T; Yajima, M, 1989) |
| "Ticlopidine was significantly effective only at 100 mg/kg p." | 1.28 | Effect of (+/-)-2-(dimethylamino)-1-[[o-(m-methoxyphenethyl)phenoxy] methyl]ethyl hydrogen succinate on experimental models of peripheral obstructive disease. ( Hara, H; Kitajima, A; Shimada, H; Tamao, Y, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Motoyama, Y | 1 |
| Sakata, Y | 1 |
| Seki, J | 1 |
| Dohi, M | 1 |
| Yoshida, K | 1 |
| Shirakura, S | 1 |
| Higo, K | 1 |
| Takeda, M | 1 |
| Karasawa, A | 1 |
| Hara, H | 1 |
| Shimada, H | 1 |
| Kitajima, A | 1 |
| Tamao, Y | 1 |
| Murai, T | 1 |
| Muraoka, K | 1 |
| Saga, K | 1 |
| Sakai, A | 1 |
| Sato, N | 1 |
| Amemiya, K | 1 |
| Yajima, M | 1 |
| Murata, T | 1 |
| Umetsu, T | 1 |
| Nishio, S | 1 |
| Goto, J | 1 |
| Araki, H | 1 |
| Otomo, S | 1 |
| Aihara, H | 1 |
5 other studies available for lauric acid and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Effect of TFC-612, a 7-thia prostaglandin E1 derivative, on a peripheral arterial occlusive disease model in rats.
Topics: Alprostadil; Animals; Arterial Occlusive Diseases; Blood Pressure; Disease Models, Animal; Lauric Ac | 1995 |
Antithrombotic effects of KW-3635, a thromboxane A2-receptor antagonist, in guinea pigs.
Topics: Animals; Arterial Occlusive Diseases; Aspirin; Benzimidazoles; Benzoxepins; Blood Coagulation; Blood | 1994 |
Effect of (+/-)-2-(dimethylamino)-1-[[o-(m-methoxyphenethyl)phenoxy] methyl]ethyl hydrogen succinate on experimental models of peripheral obstructive disease.
Topics: Animals; Arterial Occlusive Diseases; Carrageenan; Fibrinolytic Agents; Infarction; Lauric Acids; Ma | 1991 |
Effect of beraprost sodium on peripheral circulation insufficiency in rats and rabbits.
Topics: Acute Disease; Animals; Arterial Occlusive Diseases; Electric Stimulation; Epinephrine; Epoprostenol | 1989 |
A comparison of the effect of Lipo PGE1 and other related compounds on experimental peripheral arterial occlusive disease in rats.
Topics: Alprostadil; Animals; Arterial Occlusive Diseases; Dosage Forms; Lauric Acids; Male; Microspheres; P | 1986 |